Only US Research Network focused on VTE
VENUS’s purpose is to initiate and implement collaborative, multi-institutional clinical trials and/or other scientific research projects focused on thrombotic disorders in the United States. VENUS members are individual physician-scientists employed at various academic medical or other non-commercial research institutions in the U.S.
Members are organized into committees based on their research focus. Each VENUS committee is charged with organizing collaborative, multi-institutional research projects, including clinical trials, and applying for grant funds to support proposed projects.
VENUS is supported by the Hemostasis & Thrombosis Research Society, Versiti, ASH Foundation, National Blood Clot Alliance, and Anticoagulation Forum.
VENUS is Unique
The Venous thromboEmbolism Network U.S. (VENUS) is the only collaborative clinical trial research network in the U.S. focused on venous thrombosis.
VENUS Executive Committee
Lisa Baumann Kreuziger, MD, MS
Henny Billett, MD
Rachel Rosovsky, MD, MPH
Guy Young, MD
Disease Focus Committees
- Cancer and Thrombosis
- VTE Treatment and Anticoagulant Management
- Device Related Thrombosis
- Women and Thrombosis
VENUS Participating Institutions
- Arkansas Children’s Research Institute
- Beth Israel Deaconess Medical Center
- Children’s Minnesota
- Children’s National
- Cleveland Clinic
- Emory University
- Hackensack Meridian Health
- Mass General
- MD Anderson
- Montefiore Medical Center
- Newark Beth Israel Medical Center
- The Ohio State University
- Regents of the University of Colorado
- Rochester General Hospital
- Rush University
- Tulane University
- University of Alabama at Birmingham
- University of Iowa
- University of Miami
- University of Michigan
- University of North Carolina
- University of Utah
- University of Vermont
- Virginia Commonwealth University
- Wake Health
- Washington University
- Weill Cornell Medicine
VENUS includes more than 128 investigators in 38+ states.
International Network of VENous Thromboembolism (INVENT)
VENUS is a member of the International Network of VENous Thromboembolism (INVENT) Clinical Research Networks. INVENT is an independent, not-for-profit network of academic research groups.
INVENT exists to promote international collaboration between academic research networks that conduct venous thromboembolism (VTE) related clinical research and to enhance the profile, science and impact of investigator-led VTE medical research.